Cited by 195Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index.

Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology

Open access

Fonseca, Vivian A., Grunberger, George, Anhalt, Henry, Bailey, Timothy S., Blevins, Thomas, Garg, Satish K., Handelsman, Yehuda, Hirsch, Irl B., Orzeck, Eric A., Roberts, Victor Lawrence, Tamborlane, William·2016·Endocrine Practice

DOI 10.4158/ep161392.cs

Open this paper in CoChat — free account

Abstract

Objective/methods Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption of this valuable technology for the management of diabetes. The American Association of Clinical Endocrinologists and the American College of Endocrinology convened a public consensus conference February 20, 2016, to review available CGM data and propose strategies for expanding CGM access.Results Conference participants agreed that evidence supports the benefits of CGM in type 1 diabetes and that these benefits are likely to apply whenever intensive insulin therapy is used, regardless of diabetes type. CGM is likely to reduce healthcare resource utilization for acute and chronic complications, although real-world analyses are needed to confirm potential cost savings and quality of life improvements. Ongoing technological advances have improved CGM accuracy and usability, but more innovations in human factors, data delivery, reporting, and interpretation are needed to foster expanded use. The development of a standardized data report using similar metrics across all devices would facilitate clinician and patient understanding and utilization of CGM. Expanded CGM coverage by government and private payers is an urgent need.Conclusion CGM improves glycemic control, reduces hypoglycemia, and may reduce overall costs of diabetes management. Expanding CGM coverage and utilization is likely to improve the health outcomes of people with diabetes.Abbreviations A1C = glycated hemoglobin AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology ASPIRE = Automation to Simulate Pancreatic Insulin Response CGM = continuous glucose monitoring HRQOL = health-related quality of life ICER = incremental cost-effectiveness ratio JDRF = Juvenile Diabetes Research Foundation MARD = mean absolute relative difference MDI = multiple daily injections QALY = quality-adjusted life years RCT = randomized, controlled trial SAP = sensor-augmented pump SMBG = self-monitoring of blood glucose STAR = Sensor-Augmented Pump Therapy for A1C Reduction T1D = type 1 diabetes T2D = type 2 diabetes.

Integrity signals

Registry

Crossref · 10.4158/ep161392.cs

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254 · cited 1×
“The number of users in the T1D Exchange clinic registry has more than doubled to 15% in 2016 (1,25,26), and observational data collected in 2014-2015 from the T1D Exchange clinic registry support the benefits of newer devices.”
Background
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Self-citation
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e31815c31a7 · Cited by 579
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · cited 1×
“is $218 billion per year (43); hospitalizations for hypoglycemic and hyperglycemic crises may account for up to $5 billion, based on an estimated cost of approximately $17,500 per hospitalization (44-47).”
Background
Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial
Murphy, H. R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J., & Temple, R. C. (2008) · BMJ · doi:10.1136/bmj.a1680 · Cited by 358
Factors affecting blood glucose monitoring: sources of errors in measurement
Ginsberg, B. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300438 · Cited by 348
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. L. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 344
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations
Geller, A. I., Shehab, N., Lovegrove, M. C., Kegler, S. R., Weidenbach, K. N., Ryan, G. J., & Budnitz, D. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.136 · Cited by 314
Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2011) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 312
Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., Young-Hyman, D. L., Schlundt, D. G., & Clarke, W. L. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1870 · Cited by 309
Symmetrization of the Blood Glucose Measurement Scale and Its Applications
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. L. (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1655 · Cited by 258
Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0889 · Cited by 250
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Sands, A., Zambrowicz, B., Rosenstock, J., Lapuerta, P., Bode, B. W., Garg, S. K., Buse, J. B., Banks, P. L., Heptulla, R. A., Rendell, M., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2806 · Cited by 218
A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control
Munshi, M. N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.539 · Cited by 196
Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial
Allen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182 · cited 1×
“Several small-scale studies have shown that professional CGM can lead to reductions in A1C, weight loss, and/or reductions in incidence of hypoglycemia in patients with T2D when the clinician uses the data to guide therapeutic changes (27-32).”
Background
Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes
Poolsup, N., Suksomboon, N., & Kyaw, A. M. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-39 · Cited by 179
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile
Bergenstal, R. M., Ahmann, A., Bailey, T. S., Beck, R. W., Bissen, J., Buckingham, B. A., Deeb, L. C., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700234 · Cited by 173
Reduction in Hemoglobin A1c with Real-Time Continuous Glucose Monitoring: Results from a 12-Week Observational Study
Bailey, T. S., Zisser, H. C., & Garg, S. K. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0205 · Cited by 159 · cited 1×
“Table 2 summarizes some key metrics discussed by the CGM consensus group, along with their advantages, limitations, and supporting evidence (3,54-62).”
Background
Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values
Garg, S. K., & Jovanovič, L. (2006) · Diabetes Care · doi:10.2337/dc06-1361 · Cited by 147
Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data
Mazze, R. S., Lucido, D., Langer, O., Hartmann, K., & Rodbard, D. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.111 · Cited by 144
Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring
Hay, L. C., Wilmshurst, E. G., & Fulcher, G. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816427 · Cited by 143
Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial
Chase, H. P., Beck, R. W., Xing, D., Tamborlane, W. V., Coffey, J., Fox, L. A., Ives, B., Keady, J., Kollman, C., Laffel, L. M., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0021 · Cited by 142
Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes
Bode, B. W., Schwartz, S., Stubbs, H. A., & Block, J. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2361 · Cited by 137
Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study
Slover, R. H., Welsh, J. B., Criego, A. B., WEINZIMER, S. A., Willi, S. M., Wood, M. A., & Tamborlane, W. V. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00793.x · Cited by 135
Hypoglycemia in Type 2 Diabetes - More Common Than You Think
Gehlaut, R. R., Dogbey, G. Y., Schwartz, F., Marling, C. R., & Shubrook, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815581052 · Cited by 133
American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement
Bailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 130
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes
Tansey, M., Laffel, L. M., Cheng, J., Beck, R. W., Coffey, J., Huang, E. S., Kollman, C., Lawrence, J. M., Lee, J., Ruedy, K. J., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03368.x · Cited by 124
Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0846 · Cited by 121
Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Perkins, B. A., Welsh, J. B., Willi, S. M., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1248 · Cited by 118
Self-citation
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang, E. S., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Lee, J. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Tamborlane, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 118
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study
The SWITCH Study Group, Hommel, E. E., Olsen, B. S., Battelino, T., Conget, I., Schütz-Fuhrmann, I., Hoogma, R. P. L. M., Schierloh, U. H. E., Sulli, N., Gough, H., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0598-7 · Cited by 108
Validation of Measures of Satisfaction with and Impact of Continuous and Conventional Glucose Monitoring
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0015 · Cited by 103
The incidence and costs of hypoglycemia in type 2 diabetes.
Quilliam, B. J., Simeone, J. C., Ozbay, A. B., & Kogut, S. J. (2011) · PubMed · Cited by 94
Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: The DIALYDIAB pilot study
Joubert, M., Fourmy, C., Henri, P., Ficheux, M., Lobbedez, T., & Reznik, Y. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.026 · Cited by 92
Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies
Laffel, L. M. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0380 · Cited by 86
Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes: CGM and very young children with T1D
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network (DirecNet) Study Group (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00837.x · Cited by 83
Trends in Health Care Expenditure in U.S. Adults With Diabetes: 2002–2011
Ozieh, M. N., Bishu, K. G., Dismuke, C. E., & Egede, L. E. (2015) · Diabetes Care · doi:10.2337/dc15-0369 · Cited by 77
Contribution of an Intrinsic Lag of Continuous Glucose Monitoring Systems to Differences in Measured and Actual Glucose Concentrations Changing at Variable Rates in Vitro
Davey, R. J., Low, C., Jones, T. W., & Fournier, P. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400614 · Cited by 62
Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
Battelino, T., Liabat, S., Veeze, H. J., Castañeda, J., Arrieta, A., & Cohen, O. (2015) · Diabetic Medicine · doi:10.1111/dme.12825 · Cited by 59
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study
Weiss, R., Garg, S. K., Bode, B. W., Bailey, T. S., Ahmann, A., Schultz, K. A., Welsh, J. B., Shin, J., & for the ASPIRE In-Home Study Group (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0306 · Cited by 54
Are risk indices derived from CGM interchangeable with SMBG-Based indices?
Fabris, C., Patek, S. D., & Breton, M. D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815599177 · Cited by 52
Display of Glucose Distributions by Date, Time of Day, and Day of Week: New and Improved Methods
Rodbard, D. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300619 · Cited by 47
A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes
Ly, T. T., Brnabic, A. J. M., Eggleston, A., Kolivos, A., McBride, M. E., Schrover, R., & Jones, T. W. (2014) · Value in Health · doi:10.1016/j.jval.2014.05.008 · Cited by 43
The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Bronstone, A. B., & Graham, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633233 · Cited by 39
The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated Evidence
Ruedy, K. J., & Tamborlane, W. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9364-9 · Cited by 28
Benefits of Short-Term Professional Continuous Glucose Monitoring in Clinical Practice
Leinung, M. C., Nardacci, E., Patel, N., Bettadahalli, S., Paika, K., & Thompson, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0027 · Cited by 26
Diurnal Glucose Patterns of Exenatide Once Weekly: A 1-Year Study Using Continuous Glucose Monitoring with Ambulatory Glucose Profile Analysis
Mazze, R., Strock, E. S., Morgan, B., Wesley, D., Bergenstal, R. M., & Cuddihy, R. M. (2009) · Endocrine Practice · doi:10.4158/ep09046.orr · Cited by 25
Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year
Chamberlain, J. J., Dopita, D., Gilgen, E., & Neuman, A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815604633 · Cited by 24
Relationships between Glucose Variability and Conventional Measures of Glycemic Control in Continuously Monitored Patients with Type 2 Diabetes
Kohnert, K., Vogt, L., Augstein, P., Heinke, P., Zander, E., Peterson, K., Freyse, E.-J., & Salzsieder, E. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128143 · Cited by 21
Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus
Kovatchev, B., Umpierrez, G., DiGenio, A., Zhou, R., & Inzucchi, S. E. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587014 · Cited by 18
Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
Tansey, M., WEINZIMER, S. A., Beck, R. W., Ruedy, K. J., Cheng, P., Tamborlane, W. V., Kollman, C., Mauras, N., Fox, L. A., Coffey, J., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2021 · Cited by 14
Effect of liraglutide vs. NPH in combination with metformin on blood glucose fluctuations assessed using continuous glucose monitoring in patients with newly diagnosed type 2 diabetes
Ma, Z., Chen, R., Liu, Y., Yu, P., & Chen, L. (2015) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp202415 · Cited by 14
User Acceptability and Perceived Benefits of New Reports in CareLink Pro 3.0 Therapy Management Software for Diabetes
Welsh, J. B., Myers, S. J., Uhrinak, A. N., KAUFMAN, F. R., & Lee, S. W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600240 · Cited by 9
Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database.
Welsh, J. B., Kannard, B., NOGUEIRA, K., KAUFMAN, F. R., & Shah, R. V. (2010) · PubMed · Cited by 7
Continuous glucose monitoring and hypoglycemia unawareness in type 1 diabetes: a pilot study
Zalzali, M., Houdelet-Guerinot, V., Socquard, E., Thierry, A., Delemer, B., & Lukas-Croisier, C. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02326-9 · Cited by 4

Research works printed but not linked: 1

Miller, 2016, Continuous glucose monitoring in T1D patients using injections of insulin: a report from the T1D Exchange clinic registry, Diabetes Technol Ther, 18, A

Sorted by citations

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Self-citation
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Self-citation

See all 195

Authors: Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., & Tamborlane, W.
Affiliations: Tulane University (US)
Oakland University (US)
T1D Exchange (US)
University of California San Diego (US)
Texas Diabetes & Endocrinology (US)
University of Colorado Anschutz (US)
University of Washington (US)
University of Central Florida (US)
Yale University (US)
ORCID: Fonseca, Vivian A.
Grunberger, George
Bailey, Timothy S.
Blevins, Thomas
Garg, Satish K.
Handelsman, Yehuda
Hirsch, Irl B.
Tamborlane, William
Venue: Endocrine Practice
Publisher: Elsevier BV
Published: 2016-08
Volume: 22
Issue: 8
Pages: 1008-1021
ISSN: 1530-891X (ISSN-L)
DOI: 10.4158/ep161392.cs
OpenAlex: W2406099149
Cited by: 195
References: 68
Citations by year: 2026: 6 · 2025: 12 · 2024: 12 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 23 · 2019: 33 · 2018: 27 · 2017: 38 · 2016: 2
FWCI: 33.47
Type: journal article
Language: en
Open access: green
stars.library.ucf.edu
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Endocrine Practice (publishedVersion)
PubMed (publishedVersion)
Journal of International Crisis and Risk Communication Research (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: continuous glucose monitoring, diabetes management, type 1 diabetes, type 2 diabetes, intensive insulin therapy, glycemic control, hypoglycemia, healthcare resource utilization, cost-effectiveness, insurance coverage, sensor-augmented pump therapy, self-monitoring of blood glucose, health-related quality of life
MeSH terms: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Endocrinology, Humans, Quality of Life, Blood Glucose Self-Monitoring, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks